Lindsey Bs De Lott

Lindsey Bs De Lott

Auto-generated profile, based on publicly available information

Lindsey Bs De Lott

Department of Ophthalmology and Visual Science, University of Michigan, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Ophthalmology
Verified
Journal Article
Closed access
DCDean M. Cestari
Dean M. Cestari
EGEric D. Gaier
Eric D. Gaier
PBPeggy Bouzika
Peggy Bouzika
TBTaylor S. Blachley
Taylor S. Blachley
LLLindsey B. De Lott
Lindsey B. De Lott
JSJoshua D. Stein
Joshua D. Stein

1 October 2015 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
CPCrandall E. Peeler
Crandall E. Peeler
LLLindsey B. De Lott
Lindsey B. De Lott
LNLina Nagia
Lina Nagia
JLJoão Lemos
João Lemos
EEEric R. Eggenberger
Eric R. Eggenberger
WCWayne T. Cornblath
Wayne T. Cornblath
Myasthenia gravis (MG) can cause weakness of the eyelids and extraocular muscles in up to 90% of patients; approximately half of such patients will present with isolated ocular symptoms (ie, ptosis and/or diplopia only).1 The diagnosis of ocular MG (OMG) is not always clinically evident, as the pattern of deficits can mimic a cranial nerve palsy, internuclear ophthalmoplegia, or thyroid eye disease. In addition, some patients with suspected OMG do not respond to first-line treatment with pyrdiostigmine and are candidates for immunosuppressive therapy, which carries a risk of harmful adverse effects.1-3 For these reasons, ancillary testing is often used to confirm the diagnosis of OMG.

1 August 2014 in Sleep Medicine
Verified
Journal Article
Closed access
DBDevin L. Brown
Devin L. Brown
MMMollie McDermott
Mollie McDermott
AMAshkan Mowla
Ashkan Mowla
LLLindsey De Lott
Lindsey De Lott
LMLewis B. Morgenstern
Lewis B. Morgenstern
LLLynda D. Lisabeth
Lynda D. Lisabeth

1 June 2016 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
PCPatrick Coit
Patrick Coit
LLLindsey B De Lott
Lindsey B De Lott
BNBin Nan
Bin Nan
VEVictor M Elner
Victor M Elner
ASAmr H Sawalha
Amr H Sawalha
Objective To investigate the inflammatory response in giant cell arteritis (GCA) by characterising the DNA methylation pattern within the temporal artery microenvironment. Methods Twelve patients with non-equivocal histological evidence for GCA and 12 age-matched, sex-matched and ethnicity-matched controls with normal biopsies were studied. DNA was extracted from the affected portions of temporal artery tissue in patients with GCA and from histologically confirmed normal arteries in controls. Genome-wide DNA methylation status was evaluated using the Illumina Infinium HumanMethylation450 BeadChip Array. Differentially methylated loci between affected and unaffected arterial tissues were identified, and subsequent bioinformatic analysis performed. Immunohistochemistry was used to examine tissue expression patterns in temporal artery biopsies. Results We identified 1555 hypomethylated CG sites (853 genes) in affected temporal artery tissue from patients with GCA compared with normal controls. Gene ontology enrichment analysis of hypomethylated genes revealed significant representation in T cell activation and differentiation pathways, including both TH1 and TH17 signatures. Our DNA methylation data suggest a role for increased activity of the calcineurin/nuclear factor of activated T cells (NFAT) signalling pathway in GCA, confirmed by immunohistochemistry showing increased expression and nuclear localisation of NFAT1. NFAT signalling downstream targets such as interleukin (IL)-21/IL-21R and CD40L were overexpressed in GCA-affected arteries. Further, proinflammatory genes including TNF, LTA, LTB, CCR7, RUNX3, CD6, CD40LG, IL2, IL6, NLRP1, IL1B, IL18, IL21, IL23R and IFNG were hypomethylated in the cellular milieu of GCA arteries. Conclusions We characterised the inflammatory response in GCA-affected arteries using ‘epigenetic immunophenotyping’ and identified molecules and pathways relevant to disease pathogenesis in GCA.

3 January 2021 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
LLLindsey B De Lott
Lindsey B De Lott
JBJeffrey L Bennett
Jeffrey L Bennett
FCFiona Costello
Fiona Costello

1 April 2015 in Telemedicine and e-Health
Verified
Journal Article
Closed access
MWMaria Woodward
Maria Woodward
PPPatricia Ple-Plakon
Patricia Ple-Plakon
TBTaylor Blachley
Taylor Blachley
DMDavid C. Musch
David C. Musch
PNPaula Anne Newman-Casey
Paula Anne Newman-Casey
PLPaul P. Lee
Paul P. Lee
Background: The rapid rise of e-health and remote care systems will likely change the practice patterns of ophthalmologists. Although telemedicine practices are thriving in many specialties of medicine, telemedicine for ophthalmology has been limited primarily to asynchronous care for diabetic retinopathy. The goal of this research was to evaluate perspectives on and familiarity with telemedicine among eye care providers at a large tertiary-care medical center via an anonymous, descriptive survey. Results: In total, 58 eye care physicians completed surveys (response rates of 86% for physicians-in-training and 49% for faculty physicians, respectively). Although a majority of both faculty and physicians-in-training were willing to participate in telemedicine services, trainees were more likely to be willing to interpret photographs than faculty ( p =0.04). Most respondents (71%) indicated that they did not use telemedicine. Over half had received photographs (via phone or e-mail) for interpretation from referring physicians (54%) or patients (56%) within the past 3 months. A majority of providers (82%) would be willing to participate in telemedicine for consultations and for interpreting photographs, but a majority (59%) had low confidence in remote care for providing an opinion on patient care. Conclusions: Most eye care providers viewed telemedicine as part of the future of eye care but were concerned about the use of telemedicine. Although most providers did not practice telemedicine, over half of them were comfortable managing eye care consultations (including patients' photographs) via the Internet.